Medication Use in the Neonatal Intensive Care Unit: Current Patterns and Off-Label Use of Parenteral Medications

Journal of Pediatrics

Volumn 152, Issue 3, 2008, Pages

  Kumar, Praveen ^a   Walker, Jennifer K ^b   Hurt, Kristin M ^b   Bennett, Kimberly M ^b   Grosshans, Neal ^b   Fotis, Michael A ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CAFFEINE; CHLOROTHIAZIDE; CORTICOSTEROID; DEXAMETHASONE; DOPAMINE; ERYTHROPOIETIN; FENTANYL; FUROSEMIDE; GENTAMICIN; HEMATOLOGIC AGENT; HEPARIN; HYDROCORTISONE; HYPERTENSIVE FACTOR; INDOMETACIN; LORAZEPAM; METOCLOPRAMIDE; MIDAZOLAM; PHENOBARBITAL; RANITIDINE; SALBUTAMOL; SPIRONOLACTONE;

ARTICLE; CLINICAL PRACTICE; FOOD AND DRUG ADMINISTRATION; GESTATIONAL AGE; HEALTH CARE UTILIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LOW BIRTH WEIGHT; NEWBORN CARE; PARENTERAL NUTRITION; PRIORITY JOURNAL;

EID: 38949172369     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.07.050     Document Type: Article

References (18)

1. Aranda J.V., Cohen S., and Neims A.H. Drug utilization in a newborn intensive care unit. J Pediatr 89 (1976) 315-317
2. Aranda J.V., Collinge J.M., and Clarkson S. Epidemiologic aspects of drug utilization in a newborn intensive care unit. Semin Perinatol 6 (1982) 148-154
3. Aranda J.V., Clarkson S., and Collinge J.M. Changing pattern of drug utilization in a neonatal intensive care unit. Am J Perinatol 1 (1983) 28-30
4. Italian Collaborative Group on Preterm Delivery. Early neonatal drug utilization in preterm newborns in neonatal intensive care units. Dev Pharmacol Ther 11 (1988) 1-7
5. Lesko S.M., Epstein M.E., and Mitchell A.A. Recent patterns of drug use in newborn intensive care. J Pediatr 116 (1990) 985-990
6. Clark R.H., Bloom B.T., Spitzer A.R., and Gerstmann D.R. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 117 (2006) 1979-1987
7. Food and Drug Administration. The Pediatric Exclusivity Provision: January 2001 Status Report to Congress (2001), Food and Drug Administration, Rockville, MD
8. Turner S., Nunn A.J., and Choonara I. Unlicensed drug use in children in the UK. Paediatr Perinat Drug Therapy 1 (1997) 52-55
9. 't Jong G.W., Vulto A.G., de Hoog M., Schimmel K.J.M., Tibboel D., and van den Anker J.N. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics 108 (2001) 1089-1093
10. Conroy S., Choonara I., Impicciatore P., Mohn A., Arnell H., Rane A., et al. Survey of unlicensed and off-label drug use in pediatric wards in European countries. BMJ 320 (2000) 79-82
11. Pandolfini C., Impiccatore P., Provasi D., Rocchi F., Campi R., Bonati M., and Italian Paediatric Off-label Collaborative Group. Off-label use of drugs in Italy: a prospective observational and multicentre study. Acta Pediatr 91 (2002) 339-347
12. Bucheler R., Schwab M., Morike K., Kalchthaler B., Mohr H., Schroder H., et al. Off-label prescribing to children in primary care in Germany: a retrospective cohort study. BMJ 324 (2002) 1311-1312
13. O'Donnell C.P.F., Stone R.J., and Morley C.J. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 110 (2002) e52
14. Avenel S., Bomkratz A., Dassieu G., Janaud J.C., and Danan C. The incidence of prescriptions without marketing product license in a neonatal intensive care unit. Arch Pediatr 7 (2000) 143-147
15. American Academy of Pediatrics Committee on Drugs. Uses of drugs not described in the package insert (off-label uses). Pediatrics 110 (2002) 181-183
16. Hill P. Off-licence and off-label prescribing in children: litigation fears for physicians. Arch Dis Child 90 Suppl 1 (2005) i17-i18
17. Conroy S., McIntyre J., and Choonara I. Unlicensed and off-label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 80 (1999) F142-F145
18. Yeh T.F., Lin Y.J., Lin H.C., Huang C.C., Hsieh W.S., Lin C.H., et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350 (2004) 1304-1313